Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
4
100%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Other(1)

Detailed Status

Completed3
unknown1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
N/A

Trials by Phase

N/A4 (100.0%)

Trials by Status

completed375%
unknown125%

Recent Activity

0 active trials
Showing 4 of 4
completednot_applicable

Remote Ischemic Conditioning in Oncology

NCT04805346
completednot_applicable

Remote Ischemic Conditioning in HSCT

NCT04808167
completednot_applicable

Field Implementation of the autoRIC Device in STEMI

NCT03265067
unknownnot_applicable

Remote Ischemic Conditioning Using the autoRIC

NCT03318575

Clinical Trials (4)

Showing 4 of 4 trials
NCT04805346Not Applicable

Remote Ischemic Conditioning in Oncology

Completed
NCT04808167Not Applicable

Remote Ischemic Conditioning in HSCT

Completed
NCT03265067Not Applicable

Field Implementation of the autoRIC Device in STEMI

Completed
NCT03318575Not Applicable

Remote Ischemic Conditioning Using the autoRIC

Unknown

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4